Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2
NCT ID: NCT02458027
Last Updated: 2023-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2015-07-31
2016-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistant Starch on Glucose and Insulin Sensitivity in Individuals With Type 2 Diabetes
NCT00691249
Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes
NCT02400450
Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn
NCT05145998
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
NCT02146157
To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood Glucose Levels in People With Pre-diabetes: A Randomized Placebo-Controlled Parallel Arm Trial
NCT06454773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
20g Hemp Protein Shake
Hemp protein shake, 20 grams, given once at beginning of acute trial.
Hemp Shake
Hemp Protein
40 g Hemp Protein
Hemp protein shake, 40 grams, given once, at beginning of acute trial.
Hemp
Hemp Protein Shake
20 g Soybean Protein Shake
Soybean protein shake, 20 grams, given once, at beginning of acute trial.
Soybean Shake
Soybean Protein
40 g Soybean Protein
Soybean protein shake, 40 grams, given once, at beginning of acute trial.
Soybean
Soybean Protein Shake
Control Shake
Non-protein control shake, given once, at beginning of acute trial.
Control
Non-Protein Shake
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemp Shake
Hemp Protein
Hemp
Hemp Protein Shake
Soybean Shake
Soybean Protein
Soybean
Soybean Protein Shake
Control
Non-Protein Shake
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) of 18.5-29.9 kg/m2.
Exclusion Criteria
* Regularly skip breakfast
* Smokers
* Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Manitoba Harvest
OTHER
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Jones, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba, Richardson Centre for Functional Foods and Nutraceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Richardson Centre for Functional Foods and Nutraceuticals
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2014:115-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.